Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Anti-­Human CTLA4xLAG3 (Bavunalimab) Sicherheitsdatenblatt downloaden Biosimilars Bavbio Hu CHO cells B22069601-25mg

Biointron 		25 mg Anmelden
Vergleichen
Anti-­Human CTLA4xLAG3 (Bavunalimab) Sicherheitsdatenblatt downloaden Biosimilars Bavbio Hu CHO cells B22069601-50mg

Biointron 		50 mg Anmelden
Vergleichen
Anti-­Human CTLA4xLAG3 (Bavunalimab) Sicherheitsdatenblatt downloaden Biosimilars Bavbio Hu CHO cells B22069601-100mg

Biointron 		100 mg Anmelden
Vergleichen
V6 Anti-­Human B7-­H3 (Ifinatamab) Sicherheitsdatenblatt downloaden Biosimilars Ifibio Hu CHO cells B22069602-1mg

Biointron 		1 mg Anmelden
Vergleichen
V6 Anti-­Human B7-­H3 (Ifinatamab) Sicherheitsdatenblatt downloaden Biosimilars Ifibio Hu CHO cells B22069602-5mg

Biointron 		5 mg Anmelden
Vergleichen
V6 Anti-­Human B7-­H3 (Ifinatamab) Sicherheitsdatenblatt downloaden Biosimilars Ifibio Hu CHO cells B22069602-25mg

Biointron 		25 mg Anmelden
Vergleichen
V6 Anti-­Human B7-­H3 (Ifinatamab) Sicherheitsdatenblatt downloaden Biosimilars Ifibio Hu CHO cells B22069602-50mg

Biointron 		50 mg Anmelden
Vergleichen
V6 Anti-­Human B7-­H3 (Ifinatamab) Sicherheitsdatenblatt downloaden Biosimilars Ifibio Hu CHO cells B22069602-100mg

Biointron 		100 mg Anmelden
Vergleichen
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Sicherheitsdatenblatt downloaden Biosimilars Grebio Hu CHO cells B22069603-1mg

Biointron 		1 mg Anmelden
Vergleichen
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Sicherheitsdatenblatt downloaden Biosimilars Grebio Hu CHO cells B22069603-5mg

Biointron 		5 mg Anmelden
Vergleichen
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Sicherheitsdatenblatt downloaden Biosimilars Grebio Hu CHO cells B22069603-25mg

Biointron 		25 mg Anmelden
Vergleichen
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Sicherheitsdatenblatt downloaden Biosimilars Grebio Hu CHO cells B22069603-50mg

Biointron 		50 mg Anmelden
Vergleichen
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Sicherheitsdatenblatt downloaden Biosimilars Grebio Hu CHO cells B22069603-100mg

Biointron 		100 mg Anmelden
Vergleichen
V6 Anti-­Human HER3 (Patritumab) Sicherheitsdatenblatt downloaden Biosimilars Patbio Hu CHO cells B22069604-1mg

Biointron 		1 mg Anmelden
Vergleichen
V6 Anti-­Human HER3 (Patritumab) Sicherheitsdatenblatt downloaden Biosimilars Patbio Hu CHO cells B22069604-5mg

Biointron 		5 mg Anmelden
Vergleichen
V6 Anti-­Human HER3 (Patritumab) Sicherheitsdatenblatt downloaden Biosimilars Patbio Hu CHO cells B22069604-25mg

Biointron 		25 mg Anmelden
Vergleichen
V6 Anti-­Human HER3 (Patritumab) Sicherheitsdatenblatt downloaden Biosimilars Patbio Hu CHO cells B22069604-50mg

Biointron 		50 mg Anmelden
Vergleichen
V6 Anti-­Human HER3 (Patritumab) Sicherheitsdatenblatt downloaden Biosimilars Patbio Hu CHO cells B22069604-100mg

Biointron 		100 mg Anmelden
Vergleichen
Anti-­Human CD3xGPRC5D (Talquetamab) Sicherheitsdatenblatt downloaden Biosimilars Talbio Hu CHO cells B22110601-1mg

Biointron 		1 mg Anmelden
Vergleichen
Anti-­Human CD3xGPRC5D (Talquetamab) Sicherheitsdatenblatt downloaden Biosimilars Talbio Hu CHO cells B22110601-5mg

Biointron 		5 mg Anmelden
Vergleichen
Anti-­Human CD3xGPRC5D (Talquetamab) Sicherheitsdatenblatt downloaden Biosimilars Talbio Hu CHO cells B22110601-25mg

Biointron 		25 mg Anmelden
Vergleichen
Anti-­Human CD3xGPRC5D (Talquetamab) Sicherheitsdatenblatt downloaden Biosimilars Talbio Hu CHO cells B22110601-50mg

Biointron 		50 mg Anmelden
Vergleichen
Anti-­Human CD3xGPRC5D (Talquetamab) Sicherheitsdatenblatt downloaden Biosimilars Talbio Hu CHO cells B22110601-100mg

Biointron 		100 mg Anmelden
Vergleichen
Anti-­Human CD3xCEACAM5 (Cibisatamab) Sicherheitsdatenblatt downloaden Biosimilars Cibbio Hu CHO cells B22117301-1mg

Biointron 		1 mg Anmelden
Vergleichen
Anti-­Human CD3xCEACAM5 (Cibisatamab) Sicherheitsdatenblatt downloaden Biosimilars Cibbio Hu CHO cells B22117301-5mg

Biointron 		5 mg Anmelden
Vergleichen
Name Preis
Anti-­Human CTLA4xLAG3 (Bavunalimab) Anmelden Anti-Human CTLA4xLAG3 (Bavunalimab)
Typ Biosimilars
Clone Bavbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Human CTLA4xLAG3 (Bavunalimab) Anmelden Anti-Human CTLA4xLAG3 (Bavunalimab)
Typ Biosimilars
Clone Bavbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Human CTLA4xLAG3 (Bavunalimab) Anmelden Anti-Human CTLA4xLAG3 (Bavunalimab)
Typ Biosimilars
Clone Bavbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
V6 Anti-­Human B7-­H3 (Ifinatamab) Anmelden V6 Anti-Human B7-H3 (Ifinatamab)
Typ Biosimilars
Clone Ifibio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
V6 Anti-­Human B7-­H3 (Ifinatamab) Anmelden V6 Anti-Human B7-H3 (Ifinatamab)
Typ Biosimilars
Clone Ifibio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
V6 Anti-­Human B7-­H3 (Ifinatamab) Anmelden V6 Anti-Human B7-H3 (Ifinatamab)
Typ Biosimilars
Clone Ifibio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
V6 Anti-­Human B7-­H3 (Ifinatamab) Anmelden V6 Anti-Human B7-H3 (Ifinatamab)
Typ Biosimilars
Clone Ifibio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
V6 Anti-­Human B7-­H3 (Ifinatamab) Anmelden V6 Anti-Human B7-H3 (Ifinatamab)
Typ Biosimilars
Clone Ifibio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Anmelden Anti-Human CD3xClaudin18.2 (Gresonitamab)
Typ Biosimilars
Clone Grebio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Anmelden Anti-Human CD3xClaudin18.2 (Gresonitamab)
Typ Biosimilars
Clone Grebio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Anmelden Anti-Human CD3xClaudin18.2 (Gresonitamab)
Typ Biosimilars
Clone Grebio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Anmelden Anti-Human CD3xClaudin18.2 (Gresonitamab)
Typ Biosimilars
Clone Grebio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Human CD3xClaudin18.2 (Gresonitamab) Anmelden Anti-Human CD3xClaudin18.2 (Gresonitamab)
Typ Biosimilars
Clone Grebio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
V6 Anti-­Human HER3 (Patritumab) Anmelden V6 Anti-Human HER3 (Patritumab)
Typ Biosimilars
Clone Patbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
V6 Anti-­Human HER3 (Patritumab) Anmelden V6 Anti-Human HER3 (Patritumab)
Typ Biosimilars
Clone Patbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
V6 Anti-­Human HER3 (Patritumab) Anmelden V6 Anti-Human HER3 (Patritumab)
Typ Biosimilars
Clone Patbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
V6 Anti-­Human HER3 (Patritumab) Anmelden V6 Anti-Human HER3 (Patritumab)
Typ Biosimilars
Clone Patbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
V6 Anti-­Human HER3 (Patritumab) Anmelden V6 Anti-Human HER3 (Patritumab)
Typ Biosimilars
Clone Patbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Human CD3xGPRC5D (Talquetamab) Anmelden Anti-Human CD3xGPRC5D (Talquetamab)
Typ Biosimilars
Clone Talbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Anti-­Human CD3xGPRC5D (Talquetamab) Anmelden Anti-Human CD3xGPRC5D (Talquetamab)
Typ Biosimilars
Clone Talbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Human CD3xGPRC5D (Talquetamab) Anmelden Anti-Human CD3xGPRC5D (Talquetamab)
Typ Biosimilars
Clone Talbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Human CD3xGPRC5D (Talquetamab) Anmelden Anti-Human CD3xGPRC5D (Talquetamab)
Typ Biosimilars
Clone Talbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Human CD3xGPRC5D (Talquetamab) Anmelden Anti-Human CD3xGPRC5D (Talquetamab)
Typ Biosimilars
Clone Talbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Human CD3xCEACAM5 (Cibisatamab) Anmelden Anti-Human CD3xCEACAM5 (Cibisatamab)
Typ Biosimilars
Clone Cibbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Anti-­Human CD3xCEACAM5 (Cibisatamab) Anmelden Anti-Human CD3xCEACAM5 (Cibisatamab)
Typ Biosimilars
Clone Cibbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top